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Dear Editor
We have read the article by Xia et.al. entitled as
“L-carnitine ameliorated fatty liver in high-calorie diet/
STZ induced type 2 diabetic mice by improving mito-
chondrial function” with great interest [1]. In this arti-
cle, the authors concluded that L-carnitine might be
an effective liver cell protector for delaying the pro-
gression of type 2 diabetes mellitus complications.
They supported this conclusion by using biochemical
and morphological differences between control and
L-carnitine-treated groups. However, we have some
reservations the terms they used throughout the arti-
cle: Firstly, the term of “mitochondrial function” has a
very broad meaning and might be a little bit confusing
as well. As known, mitochondria basically have three
biochemical systems: i) b-oxidation, ii) tricarboxylic
acid cycle (TCA cycle) and iii) electron transport
chain. Although all these systems are interconnected
and coexist in mitochondria at the same time, only
dysfunctions of electron transport chain are enumer-
ated among the mitochondrial diseases. In this article,
we understand that the mitochondrial complex activities
were not measured at all. Therefore, we think that the
conclusion saying “L-carnitine stimulates fat metabo-
lism” is acceptable. But, using the term of “improvement
of mitochondrial function” in this context is not scienti-
fically very appropriate. Secondly, the authors did not
describe the method(s) they used in “morphological
assessment of hepatic tissue” in detail. They said that
tissue samples have been fixed in 4% paraformaldehyde
in the third page of the paper. But, as far as we know,
oil red O staining works only with fresh frozen tissues.
Besides, the red dots in figure 2 were presented as lipid
droplets. If these are lipid droplets, then the other
unstained vacuoles in the same figure were remained to
be identified. We think that the tissues stained with oil
red O must be fresh-frozen samples, and at least some
of that unstained vacuoles were actually freezing
artifacts. Discrimination between freezing artifacts and
lipid vacuoles are important because the authors
assumed that L-carnitine was decreasing “lipid area per-
centage” in hepatic tissue.
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